Qpex Biopharma Patents – Insights & Stats (Updated 2023)

Qpex Biopharma has a total of 95 patents globally, out of which 34 have been granted. Of these 95 patents, more than 93% patents are active. The United States of America is where Qpex Biopharma has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Qpex Biopharma.

Qpex Biopharma was founded in 2018. Qpex works operates as a biotechnology company. The company is focused on creating novel antibiotics to counteract the increasing problem of antibiotic resistance around the world.

Do read about some of the most popular patents of Qpex Biopharma which have been covered by us in this article and also you can find Qpex Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Qpex Biopharma patent portfolio.

How many patents do the Founder and CEO of Qpex Biopharma have?

The Founder and CEO Michael Dudley have 0 patents.

How many patents does Qpex Biopharma have?

Qpex Biopharma has a total of 95 patents globally. These patents belong to 16 unique patent families. Out of 95 patents, 89 patents are active.

How Many Patents did Qpex Biopharma File Every Year?

Qpex Biopharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantQpex Biopharma Applications FiledQpex Biopharma Patents Granted
202318
2022128
2021197
2020115
2019103
2018141
2017191
201571
20142

How many Qpex Biopharma patents are Alive/Dead?

Worldwide Patents

Qpex Biopharma Patent Portfolio

How Many Patents did Qpex Biopharma File in Different Countries?

Qpex Biopharma Worldwide Patent Filing

Countries in which Qpex Biopharma Filed Patents

CountryPatent
United States Of America14
Europe8
Taiwan6
China6
Canada6
Australia5
Brazil5
Hong Kong (S.A.R.)5
India5
Israel4
Mexico4
Germany2
South Africa2
Austria2
Indonesia1
Philippines1
Spain1
Poland1
Saudi Arabia1
Portugal1
Macao1
Singapore1
Ukraine1
Colombia1
Denmark1
Viet Nam1
Malaysia1
Chile1
Norway1

Where are Research Centers of Qpex Biopharma Patents Located?

R&D Centres of Qpex Biopharma

10 Best Qpex Biopharma Patents

US9132140B2 is the most popular patent in the Qpex Biopharma portfolio. It has received 28 citations so far from companies like Rempex Pharmaceuticals, Enanta Pharmaceuticals, VenatoRx Pharmaceuticals.

Below is the list of 10 most cited patents of Qpex Biopharma:

Publication NumberCitation Count
US9132140B228
US9642869B220
US9963467B212
US10206937B29
WO2019075084A17
US10294249B24
US10662205B22
US10618918B22
US10570159B22
CN111212843A2

What are Qpex Biopharma key innovation segments?

What Technologies are Covered by Qpex Biopharma?

The chart below distributes patents filed by Qpex Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Qpex Biopharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Qpex Biopharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Qpex Biopharma?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.